Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 1 | uM | 9 | 5000.00 | 2808.68 | 6696.00 | 6918.00 | 0.9679 | 0.9505 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 6853.00 | 6918.00 | 0.9906 | 0.9855 | |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 6714.00 | 6918.00 | 0.9705 | 0.9545 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 5000.00 | 2808.68 | 4704.00 | 6918.00 | 0.6800 | 0.4867 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 5000.00 | 2808.68 | 6860.00 | 6918.00 | 0.9916 | 0.9871 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 5000.00 | 2808.68 | 6999.00 | 6918.00 | 1.0117 | 1.0180 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 5000.00 | 2808.68 | 7074.00 | 6918.00 | 1.0225 | 1.0346 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 5000.00 | 2808.68 | 7228.00 | 6918.00 | 1.0448 | 1.0686 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 5000.00 | 2808.68 | 6928.00 | 6918.00 | 1.0014 | 1.0022 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7179.00 | 6918.00 | 1.0377 | 1.0578 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 5000.00 | 2808.68 | 7129.00 | 6918.00 | 1.0305 | 1.0467 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7304.00 | 6918.00 | 1.0558 | 1.0853 | |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 5000.00 | 2808.68 | 7304.00 | 6918.00 | 1.0558 | 1.0853 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 5000.00 | 2808.68 | 2617.00 | 6918.00 | 0.3783 | -0.0529 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 5000.00 | 2808.68 | 7277.00 | 6918.00 | 1.0519 | 1.0793 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 6678.00 | 6918.00 | 0.9653 | 0.9464 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 2189.00 | 6918.00 | 0.3164 | -0.1744 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 5000.00 | 2808.68 | 6777.00 | 6918.00 | 0.9796 | 0.9686 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7279.00 | 6918.00 | 1.0522 | 1.0798 | |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 5000.00 | 2808.68 | 3473.00 | 6918.00 | 0.5020 | 0.1773 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 6766.00 | 6918.00 | 0.9780 | 0.9661 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 5000.00 | 2808.68 | 7046.00 | 6918.00 | 1.0185 | 1.0284 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 4422.00 | 6918.00 | 0.6392 | 0.4177 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 6926.00 | 6918.00 | 1.0012 | 1.0018 | |
| MCF 10A | 0 | uM | 9 | 156.25 | 46.09 | 163.00 | 237.25 | 0.6870 | 0.7064 |